Any feedback?
Literature summary for 3.4.24.35 extracted from
- Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease (2009), Clin. Exp. Immunol., 157, 300-309.
Activating Compound
| Activating Compound | Comment | Organism | Structure |
|---|---|---|---|
| 4-aminophenylmercuric acetate | 1 mM | Mus musculus |  |
| tumor necrosis factor-alpha | - |
Mus musculus |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| doxycycline | doxyxycline inhibits directlyMMP-9 enzymatic activity derived from tumor necrosis factor-alpha-stimulated vascular smooth muscle cells | Mus musculus | |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Mus musculus | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| vascular smooth muscle cell | - |
Mus musculus | - |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| Gelatin + H2O | - |
Mus musculus | ? | - |
? | |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| matrix metalloproteinase-9 | - |
Mus musculus |
| MMP-9 | - |
Mus musculus |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
